Cell Source market-risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for Cell Source or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
Cell
Cell Source has current Market Risk Adjusted Performance of 0.1427.
MRAP
=
ER[a] + (1/BETA - 1)
X
ER[a] - RFR)
=
0.1427
ER[a]
=
Expected return on investing in Cell Source
RFR
=
Risk Free Rate of return. Typically T-Bill Rate
BETA
=
Beta of the asset with market or selected benchmark.
Cell Market Risk Adjusted Performance Relative To Other Indicators
Cell Source is rated fourth in market risk adjusted performance category among its peers. It is currently under evaluation in maximum drawdown category among its peers reporting about 453.70 of Maximum Drawdown per Market Risk Adjusted Performance. The ratio of Maximum Drawdown to Market Risk Adjusted Performance for Cell Source is roughly 453.70
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.